Human medicines: highlights of 2017

January 23, 2018 – The European Medicines Agency (EMA) has published an overview of its key recommendations of 2017 regarding the authorisation of new medicines and the safety monitoring of medicines. Advances in medicines authorisations are essential for public health as they have the potential to improve the treatment of diseases. In 2017, EMA recommended 92 medicines for marketing authorisation. Of these, 35 had a new active substance, which has … (leggi tutto)